Jeff Yass’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
Other funds holding VVOS
Jeff Yass's VVOS Position: Q3 2026 in Review
Jeff Yass increased its Vivos Therapeutics (VVOS) stake by 109% in Q3 2026, buying an estimated $3.31K and bringing the position to 21,087 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #13313.
Jeff Yass first reported a position in VVOS in Q3 2021 and has held it in 6 quarters since. The position peaked at $222K in Q3 2021. 27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.
- Jeff Yass held 21,087 shares of Vivos Therapeutics worth $3.12K as of Q3 2026.
- Jeff Yass bought 11,012 Vivos Therapeutics shares in Q3 2026, an estimated $3.31K.
- Vivos Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13313 holding.
- Jeff Yass first reported a position in Vivos Therapeutics in Q3 2021 and has held it in 6 quarters since.
- Jeff Yass's Vivos Therapeutics position peaked at $222K in Q3 2021.
- 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.